Gene · 57291
DANCR: differentiation antagonizing non-protein coding RNA
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. DANCR: differentiation antagonizing non-protein coding RNA. Genes, record 57291. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/57291
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P0C864 | Putative uncharacterized protein DANCR | 163 | 0 | HGNC |
Source UniProt
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants262
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DANCR papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA043703 | Case Comprehensive Cancer Center Support Grant | 3 | 2025 |
| R01CA235152 | Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy | 3 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 3 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
| T32CA154274 | Training Grant in Cancer Biology | 2 | 2025 |
| I01BX004837 | Role of nitro-fatty acids in BBB stabilization and post-stroke neurovascular protection | 1 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 1 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 1 | 2025 |
1 to 10 of 262Source NIH's project files
See all 262 nih grantsPapers1,333
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNA DANCR Enhances Inflammatory Response in Allergic Rhinitis by Inhibiting miR-338-3p. | Am J Rhinol Allergy | 2026 | 42725898 | PubTator, text mining | PubMed |
| Regulation of PI3K Signaling by lncRNAs in Breast Cancer: A Mini-Review. | Mini Rev Med Chem | 2026 | 42708264 | PubTator, text mining | PubMed |
| Regulatory role of lncRNA DANCR in osteogenic differentiation of bone marrow mesenchymal stem cells through targeting the miR-19a-3p/PTEN/AKT/mTOR pathway. | In Vitro Cell Dev Biol Anim | 2026 | 42686955 | PubTator, text mining | PubMed |
| Endothelial DANCR deficiency promotes atherosclerotic plaque instability by targeting ribosomal protein L22. | J Adv Res | 2026 | 42668039 | PubTator, text mining | PubMed |
| Dysregulated lncRNAs are associated with the progressive arterial phenotype in Hutchinson-Gilford Progeria Syndrome. | Geroscience | 2026 | 42601545 | PubTator, text mining | PubMed |
| SnoRNA and SNHG in Bladder Cancer: Molecular Mechanisms and Clinical Significance. | Curr Issues Mol Biol | 2026 | 42510903 | PubTator, text mining | PubMed |
| Exploring the Role of Long Non-Coding RNAs in Mediating Cisplatin Resistance in Glioma/Glioblastoma Cells. | Int J Mol Sci | 2026 | 42450275 | PubTator, text mining | PubMed |
| The DANCR/miR-145-5p/CD133 Axis Drives Osteosarcoma Stemness and Progression: Implications for Tumor Biology and Therapeutic Innovation. | Cells | 2026 | 42439689 | PubTator, text mining | PubMed |
| Exploring New Frontiers in Bone Metabolism: Role and Potential of lncRNA DANCR. | Wiley Interdiscip Rev RNA | 2026 | 42235596 | PubTator, text mining | PubMed |
| Noncoding navigators of vascular smooth muscle cells: lncRNAs at the interface of vascular plasticity and therapeutic intervention. | Life Sci | 2026 | 42219081 | PubTator, text mining | PubMed |
1 to 10 of 1,333
See all 1,333 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57291
GET https://conductscience.org/api/genes/v1/57291/grants?page=2